Medtronic Inc

MDT-N

Analysis and Opinions about MDT-N

Signal
Opinion
Expert
COMMENT
COMMENT
July 25, 2014

Used to be a dividend aristocrat in that it paid an increasing dividend every single year, for a long period of time. Good balance sheet, leveraged to the tool market in the medical space. Somewhat slower growth during the recession. They are acquiring Covidien (COV-N) and will re-base in Ireland giving them lower taxes. This will accelerate their growth. Longer-term, if you buy the story, you’ll be okay, but it is a multi-year story. A slow growth story.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
July 25, 2014

Used to be a dividend aristocrat in that it paid an increasing dividend every single year, for a long period of time. Good balance sheet, leveraged to the tool market in the medical space. Somewhat slower growth during the recession. They are acquiring Covidien (COV-N) and will re-base in Ireland giving them lower taxes. This will accelerate their growth. Longer-term, if you buy the story, you’ll be okay, but it is a multi-year story. A slow growth story.

TOP PICK
TOP PICK
July 18, 2014

On the cusp of a transformational acquisition, the $43 billion purchase of Covidian (COV-N). This changes their headquarters with a tax inversion deal, making Covidian a 30% owner of the new Medtronic. In order for a tax inversion to take place, you have to own at least 20%, so maybe the extra buffer of 30% will appease regulators, and keep everybody happy. This would allow them to have foreign profit, somewhere in the realm of about $14 billion, and be able to re-disperse them among their existing shareholders. A good line of sight for a growing dividend, further share buybacks, as well as future tuck in acquisitions. This deal would make them the biggest and most diversified medical devices company globally. Also, developing a series of new products. Yield of 1.97%.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
July 18, 2014

On the cusp of a transformational acquisition, the $43 billion purchase of Covidian (COV-N). This changes their headquarters with a tax inversion deal, making Covidian a 30% owner of the new Medtronic. In order for a tax inversion to take place, you have to own at least 20%, so maybe the extra buffer of 30% will appease regulators, and keep everybody happy. This would allow them to have foreign profit, somewhere in the realm of about $14 billion, and be able to re-disperse them among their existing shareholders. A good line of sight for a growing dividend, further share buybacks, as well as future tuck in acquisitions. This deal would make them the biggest and most diversified medical devices company globally. Also, developing a series of new products. Yield of 1.97%.

BUY
BUY
February 7, 2014

Is this a good time to get into health care stocks and what would you recommend? Likes Abbott Labs (ABT-N) very much. Spun off their pharmaceutical R&D business about 2 years ago and split themselves up into 4 different divisions. If looking at global healthcare companies, you can’t go wrong with something like Johnson & Johnson (JNJ-N). Products are cheap and they can easily raise costs. Also likes Medtronics (MDT-N) which is a device manufacturer.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
February 7, 2014

Is this a good time to get into health care stocks and what would you recommend? Likes Abbott Labs (ABT-N) very much. Spun off their pharmaceutical R&D business about 2 years ago and split themselves up into 4 different divisions. If looking at global healthcare companies, you can’t go wrong with something like Johnson & Johnson (JNJ-N). Products are cheap and they can easily raise costs. Also likes Medtronics (MDT-N) which is a device manufacturer.

COMMENT
COMMENT
August 21, 2013

Likes the company and if you are comfortable with this, he thinks the medical device space is very positive demographically. You could hold this for the longer-term.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
August 21, 2013

Likes the company and if you are comfortable with this, he thinks the medical device space is very positive demographically. You could hold this for the longer-term.

SELL
SELL
November 9, 2012

Done well, constantly makes money. Incredible debt load relative to revenues. Insiders have not really been selling. Great company and pays a nice dividend but he would be looking to sell it - next year to defer tax.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
November 9, 2012

Done well, constantly makes money. Incredible debt load relative to revenues. Insiders have not really been selling. Great company and pays a nice dividend but he would be looking to sell it - next year to defer tax.

BUY
BUY
October 18, 2010
(Market Call Minute) Suffered from litigation, but great technology and dominant market share in many areas.
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
October 18, 2010
(Market Call Minute) Suffered from litigation, but great technology and dominant market share in many areas.
BUY
BUY
September 15, 2010
Well run leader in global medical technology including diagnostic testing and medical equipment used in surgeries. 25-year history of increasing dividends annually. Strong Cdn$ makes it an attractive buy. Good entry point.
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
September 15, 2010
Well run leader in global medical technology including diagnostic testing and medical equipment used in surgeries. 25-year history of increasing dividends annually. Strong Cdn$ makes it an attractive buy. Good entry point.
PAST TOP PICK
PAST TOP PICK
August 17, 2010
(A Top Pick Apr 21/09. Up 18.59%.) Sold out at a substantially higher price and made at least 50%.
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
August 17, 2010
(A Top Pick Apr 21/09. Up 18.59%.) Sold out at a substantially higher price and made at least 50%.
PAST TOP PICK
PAST TOP PICK
July 8, 2010
(A Top Pick Apr 21/09. Up 24.54%.) Sold his holdings but has now come down nicely and maybe in his portfolio next month.
Show full opinionHide full opinion
(A Top Pick Apr 21/09. Up 24.54%.) Sold his holdings but has now come down nicely and maybe in his portfolio next month.
PAST TOP PICK
PAST TOP PICK
May 27, 2010
(A Top Pick April 21/09. Up 30.27%.) Either came close to his model price or he found something of more value so he sold his holdings.
Show full opinionHide full opinion
(A Top Pick April 21/09. Up 30.27%.) Either came close to his model price or he found something of more value so he sold his holdings.
PAST TOP PICK
PAST TOP PICK
April 1, 2010
(A Top Pick April 21/09. Up 49.77%.) Sold his holdings at a good gain.
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
April 1, 2010
(A Top Pick April 21/09. Up 49.77%.) Sold his holdings at a good gain.
PAST TOP PICK
PAST TOP PICK
February 3, 2010
(A Top Pick Feb 24/09. Up 30.52%.)
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
February 3, 2010
(A Top Pick Feb 24/09. Up 30.52%.)
BUY
BUY
August 13, 2009
Likes med-tech space. Space has historically traded at 20 PE’s and up. Growth is very good. Demographics are very positive. Currently out of favour because of fears of what the government will do to the industry. Trading at one of the lowest multiples in its 20-year history.
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
August 13, 2009
Likes med-tech space. Space has historically traded at 20 PE’s and up. Growth is very good. Demographics are very positive. Currently out of favour because of fears of what the government will do to the industry. Trading at one of the lowest multiples in its 20-year history.
TOP PICK
TOP PICK
Medtronic Inc (MDT-N)
April 21, 2009
Model $42.48.
TOP PICK
TOP PICK
February 24, 2009
He has a model price of $41.29 giving it a 21% positive differential. Just reported greater earnings. 2% yield.
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
February 24, 2009
He has a model price of $41.29 giving it a 21% positive differential. Just reported greater earnings. 2% yield.
Showing 46 to 60 of 79 entries